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The published data on dilated cardiomyopathy in children 
are sparse and little is known about the long-term clinical 
course and the factors that may influence prognosis for 
better or worse. Such information is badly needed. As 
cardiac transplantation becomes more effective, the proper 
timing for heart replacement in a child with cardiomyopathy 
becomes critical. The death of a young patient with cardio-
myopathy who could have survived with a transplanted 
heart is a tragedy. On the other hand, premature transplan-
tation in a child who is destined to lead a relatively normal 
existence for a number of years presents risks, morbidity, 
life-style requirements and costs that are unnecessary and 
unacceptable. 
Management of dilated cardiomyopathy in children. What 
do we know and what do we need to know to better manage 
children with dilated cardiomyopathy? Etiology is a primary 
consideration. Progress is being made, but the underlying 
cause for the vast majority of cases of dilated cardiomyop-
athy remains unknown. Undoubtedly there are mUltiple 
causes, often leading to a final pathway of clinically similar 
myopathies. Without basic knowledge preventive measures 
are not possible. On a clinical basis, physicians cannot look 
to prospective studies for guidance regarding treatment of 
children with dilated cardiomyopathy. Reliable predictive 
risk factors have not been identified by multivariate analy-
ses. Thus, pediatric cardiologists must tum to retrospective 
studies as an adjunct to clinical judgment in considering 
management options. There have been a scattering of such 
reports (1-5) concerning dilated cardiomyopathy in children 
and only limited data are available. 
Thus, as might be expected, only very basic conclusions 
have emerged that are generally accepted by the medical 
community: 1) Some children with established dilated car-
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diomyopathy live a long time in a relatively stable clinical 
state; and 2) patients with progressive myocardial dysfunc-
tion associated with symptoms of congestive heart failure or 
serious rhythm disturbances, or both, have a poor prognosis. 
An important controversial question that remains unan-
swered for both adults and children with dilated cardiomy-
opathy is whether cardiac arrhythmias represent an indepen-
dent risk factor. Most ofthe published discussion concerning 
rhythm disturbances in dilated cardiomyopathy has focused 
on ventricular arrhythmias, but a report (6) in this issue of 
the Journal has slightly shifted the emphasis in the pediatric 
age group to supraventricular arrhythmias-specifically, 
atrial fibrillation and flutter. 
The present study. Friedman et al. (6) reviewed the data 
in 63 children with dilated cardiomyopathy. They present 
some important information on natural history. The 5 year 
survival rate was in the range of 80% and most deaths 
occurred in the first few years after diagnosis. Other series 
(1-5) have reported higher mortality rates. As emphasized in 
these published studies, symptomatic chronic congestive 
heart failure was associated with a poor prognosis. Some 
information regarding the effect of arrhythmias is presented 
in the report of Friedman et al. (6). However, as with other 
retrospective studies, there are few firm predictive data. 
Five of 29 patients in whom an arrhythmia was identified 
during exercise study or Holter ambulatory electrocardio-
graphic (EeG) monitoring died. Among 34 patients with no 
documented arrhythmias, 5 patients died but none had had 
Holter monitor studies. Three of the 10 deaths were classi-
fied as sudden. It is very likely that the occurrence of sudden 
death is related to a rhythm disturbance whether or not mild 
(frequent premature ventricular complexes) or severe (ven-
tricular tachycardia, atrial fibrillation/flutter) rhythm distur-
bances were noted earlier. 
Ventricular versus atrial arrhythmias. The relation of 
ventricular and atrial arrhythmias to outcome has not been 
clear, although several publications (1-6) appear to confirm 
that patients who have cardiac arrhythmias in the presence 
of heart failure have a poor prognosis. In contrast to others, 
Friedman et al. (6) found that atrial arrhythmias were more 
common than ventricular rhythm disorders. Atrial fibrilla-
tion/flutter was documented in 10 patients and ventricular 
tachycardia was noted in 6 children during their clinical 
course. However, including these patients and others who 
had less significant ectopic activity, the authors (6) conclude 
that" ... the presence or absence of any type of arrhythmia 
was not predictive of death, having an odds ratio of only 
1.1: 1. " In contrast, the odds ratio for death with congestive 
heart failure was 11.7: 1 and for persistent ST -T wave 
changes, 16.6:1. Despite the low odds ratio for arrhythmias, 
the authors strongly suggest that atrial flutter/fibrillation may 
be an important predictor of myocardial dysfunction and 
they advise vigorous management of children with cardio-
myopathy who have these arrhythmias. Although these 
recommendations are not based on definitive information, 
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few would argue their merits. Undoubtedly, most physicians 
would also suppress ventricular tachycardia in children with 
dilated cardiomyopathy. The meaning of frequent single 
ventricular premature beats remains unclear. 
Does treatment of arrhythmias improve prognosis? Docu-
mentation of whether "control" of arrhythmias improves 
prognosis is extremely difficult. In patients who are retro-
spectively analyzed with use of an occasional EeG and little 
or no long-term monitoring, this simply cannot be deter-
mined. In the present study (6) only 22 of 63 patients are 
reported to have had a Holter monitor study; 20 had two 
such studies. Judgments regarding the efficacy of antiar-
rhythmic treatment would require much more extensive 
monitoring and evaluation. The absence of a previously 
noted rhythm abnormality on a random EeG cannot be said 
to indicate that a rhythm disorder is controlled. It is possible 
that 1 or 2 h later, the EeG could once again show the 
arrhythmia to be present, and no different from or perhaps 
even more severe than the earlier arrhythmia. Even with 
extensive Holter monitoring, the findings may vary mark-
edly in untreated patients. This study does not include 
information as to how often the patients were seen at 
follow-up study, how patients with arrhythmias were 
treated, whether patients were symptomatic because of 
rhythm disorders or if the symptoms disappeared with 
treatment. The efficacy of pharmacologic antiarrhythmic 
therapy in children with dilated cardiomyopathy remains 
unknown. There have been no published accounts of pedi-
atric experience with an implanted defibrillator, but this 
approach may be useful in selected cases. 
Management decisions. The question of whether cardiac 
arrhythmias are an independent predictor of death in chil-
dren with dilated cardiomyopathy in the absence of con-
founding variables (such as congestive heart failure, ST-T 
wave changes and historical data relating to familial disease) 
remains unanswered. Sudden death implies the presence of a 
terminal arrhythmia, but the presence or absence of previous 
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rhythm abnormalities may not be predictive. The effect of 
antiarrhythmic treatment is not known. Data have not been 
provided from the published retrospective analyses to guide 
the physician who must consider the timing for cardiac 
transplantation in a child with cardiomyopathy who appears 
to be in relatively stable condition. At present it is prudent to 
consider any child with persistent dilated cardiomyopathy to 
be a candidate for heart transplantation. Key factors that 
may affect judgment regarding urgency include progressive 
myocardial dysfunction, severe ventricular or atrial arrhyth-
mias; syncope; elevated right atrial pressure; marked EeG 
changes (such as abnormal ST segments and left ventricular 
conduction delay); familial disease and systemic or pulmo-
nary embolism, or both. Specific information as to which 
combination of these and other variables might provide 
reliable criteria for management decisions could emerge 
from experience with dilated cardiomyopathy in children; 
conclusions would not be contaminated by the presence of 
classic ischemic heart disease. However, the small number 
of pediatric cases available for study does not bode well for 
a clear-cut answer from a single institution. The argument 
for a prospective multicenter cooperative study is a strong 
one. 
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